We use cookies to give you a better experience. Carry on browsing if you're happy with this, or read our cookies policy for more information.

Skip main navigation

Resistance around the globe

Dr. Rossana Rosa shows how to use the Center for Disease Dynamics, Economic and Policy’s (CDDEP) Resistance Map.
9.2
The Centre for Disease Dynamics, Economics and Policy has developed a Resistance Map. This is an interactive collection of charts and maps that summarise national and subnational data on anti-microbial use and resistance worldwide. The primary sources of data are public and private laboratory networks that routinely collect anti-microbial resistance test results. We can explore antibiotic resistance by pathogen, and compare resistance to different antibiotics across countries, as well as observing trends over time. For example, we can compare E. coli resistance rate to fluoroquinolones across different countries. Let’s see.
64.3
Here we find that, in the United States, 35% of the isolates tested were resistant to fluoroquinolones. Let’s compare this with India where 84% of the isolates tested were resistant. What’s the situation in say, Australia? Well, there, 13% of the isolates where resistant to fluoroquinolones. Let’s evaluate now another antibiotic, third generation cephalosporins, for example. Here we see that, in the United States, 16% of the isolates tested were resistant to third generation cephalosporins. In India, 83% of the isolates tested were resistant. And in Australia, only 11%.
122.2
Let’s try a different pathogen now, klebsiella pneumoniae. In a different antibiotic, piperacillin and tazobactam, In the United States, 30% of the isolates tested were resistant. In India, it was 63%. And in Australia, 4%. We can also explore rates of antibiotic resistance by country.
158.2
Now, I practice in the United States, and more specifically in what’s considered the west north central region. So let’s see what’s the situation with E. coli and fluoroquinolones in this region.
176.9
I find that, in the west north central region, 18% of the isolates tested were resistant to fluoroquinolones, compared to the south Atlantic region– where I used to practice– where 35% of the isolates were resistant.
195
Now go ahead and look for information of interest to your own region and practice.
Knowledge of local, regional and international resistance patterns can be useful in directing empiric antimicrobial therapy.
Importance of the awareness of the geographic differences in antimicrobial resistance rates is highlighted by the modern day ease of international travel and medical tourism.
In this video, Dr. Rossana Rosa shows how to use the Center for Disease Dynamics, Economic and Policy’s (CDDEP) Resistance Map, an interactive tool that summarises national and subnational data on antimicrobial use and resistance worldwide.
Once you have viewed this video go to the CDDEP website to interrogate the maps for yourself.
This article is from the free online

Challenges in Antibiotic Resistance: Gram Negative Bacteria

Created by
FutureLearn - Learning For Life

Our purpose is to transform access to education.

We offer a diverse selection of courses from leading universities and cultural institutions from around the world. These are delivered one step at a time, and are accessible on mobile, tablet and desktop, so you can fit learning around your life.

We believe learning should be an enjoyable, social experience, so our courses offer the opportunity to discuss what you’re learning with others as you go, helping you make fresh discoveries and form new ideas.
You can unlock new opportunities with unlimited access to hundreds of online short courses for a year by subscribing to our Unlimited package. Build your knowledge with top universities and organisations.

Learn more about how FutureLearn is transforming access to education